The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis
Article in Nature Communications (May 2024)
The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.
A short review on CRP synthesis inhibition in cardiovascular disease
Article in Frontiers in Drug Discovery (March 2024)
Effectiveness of HMG-CoA reductase inhibitors on inflammation and metabolic markers in the US-Mexico border Hispanic population
Article in Journal of Investigative Medicine (March 2024)